@inproceedings{2954053,
    title = "A substudy of the phase 3 ENDEAVOR study: serial echocardiographic assessment of patients with relapsed multiple myeloma (RMM) receiving carfilzomib plus dexamethasone or bortezomib plus dexamethasone",
    author = "Hajekr, R and Russell, SD and Lyon, A and Lenihan, D and Moreau, P and Joshua, D and Chng, WJ and Palumbo, A and Goldschmidt, H and Facon, T and others",
    year = "2016",
    pages = "263--263",
    booktitle = "Haematologica"
}